BSEBoard MeetingResults12 Aug 2026
Eiko Lifesciences Ltd
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments ....
Eiko Lifesciences Ltd has announced its un-audited standalone and consolidated financial results for the quarter ended 30th June, 2026, along with a limited review report issued by its statutory auditors.
Read more →📎 1 attachment